| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/21/2005 | EP1575988A2 Short peptides from the '2nd loop' of 7 transmembrane receptor which selectively modulate signal transduction |
| 09/21/2005 | EP1575986A2 Peptides and methods for cell death regulation |
| 09/21/2005 | EP1575984A2 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade |
| 09/21/2005 | EP1575981A1 Angiogenic compounds and uses thereof |
| 09/21/2005 | EP1575978A2 Diagnosis of sepsis or sirs using biomarker profiles |
| 09/21/2005 | EP1575917A2 Hemipteran muscarinic receptor |
| 09/21/2005 | EP1575916A2 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain |
| 09/21/2005 | EP1575903A1 Compounds for the inhibition of rotamases |
| 09/21/2005 | EP1575707A1 Method and apparatus for aligning elongated microbeads in order to interrogate the same |
| 09/21/2005 | EP1575658A2 Screening and therapeutic methods for treating circadian rhythm disorders |
| 09/21/2005 | EP1575619A1 Oligosaccharides and conjugates thereof for the treatement of pseudomonas bacteria infection |
| 09/21/2005 | EP1575602A2 Methods for treating cancer using porimin as a target |
| 09/21/2005 | EP1575573A2 Agents and methods for treatment of disease by oligosaccharide targeting agents |
| 09/21/2005 | EP1575553A2 In vivo production of cyclic peptides for inhibiting protein-protein interaction |
| 09/21/2005 | EP1575529A2 Peptides and methods of screening immunogenic peptide vaccines against alzheimer's disease |
| 09/21/2005 | EP1575525A2 Cell surface tropomyosin as a target of angiogenesis inhibition |
| 09/21/2005 | EP1575524A2 Proliferated cell lines and uses thereof |
| 09/21/2005 | EP1575520A2 A process for preparation of an agglutination reagent for rapid detection of typhoid |
| 09/21/2005 | EP1575518A2 Compositions, organisms and methodologies employing a novel human kinase |
| 09/21/2005 | EP1575512A2 Methods and compositions for prostate epithelial cell differentiation |
| 09/21/2005 | EP1575511A2 A new target for angiogenesis and anti-angiogenesis therapy |
| 09/21/2005 | EP1575510A2 Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation |
| 09/21/2005 | EP1575509A2 Epha2 agonistic monoclonal antibodies and methods of use thereof |
| 09/21/2005 | EP1575505A2 Codon-optimized polynucleotide-based vaccines against bacillus anthracis infection |
| 09/21/2005 | EP1575502A2 Compositions and methods involving nuclear hormone receptor site ii |
| 09/21/2005 | EP1575500A2 Mesothelin vaccines and model systems |
| 09/21/2005 | EP1575497A2 Novel composition and methods for the treatment of psoriasis |
| 09/21/2005 | EP1575496A2 Colon tumor specific binding peptides |
| 09/21/2005 | EP1575492A2 Cancer-linked gene as target for chemotherapy |
| 09/21/2005 | EP1575486A2 Method and compositions for identifying anti-hiv therapeutic compounds |
| 09/21/2005 | EP1575483A2 Attenuated gram negative bacteria |
| 09/21/2005 | EP1575482A2 Compositions and method of treating alzheimer's disease |
| 09/21/2005 | EP1575481A2 Methods to increase or decrease bone density |
| 09/21/2005 | EP1575480A2 Compositions and methods for the treatment of immune related diseases |
| 09/21/2005 | EP1575479A2 Hsp peptides and analogs for modulation of immune responses via antigen presenting cells |
| 09/21/2005 | EP1575422A2 Optical sensor and methods for measuring molecular binding interactions |
| 09/21/2005 | EP1575420A2 Prostate cancer biomarkers |
| 09/21/2005 | EP1575417A2 Methods for prediction and prognosis of cancer, and monitoring cancer therapy |
| 09/21/2005 | EP1575416A2 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 09/21/2005 | EP1575354A1 Melusin, a muscle specific protein, as a drug target for prevention and treatment of heart failure |
| 09/21/2005 | EP1490672A4 An electrical condition monitoring method for polymers |
| 09/21/2005 | EP1478923A4 Assay for anti-ingap antibodies |
| 09/21/2005 | EP1430154A4 Enzyme-amplified redox microarray detection process |
| 09/21/2005 | EP1377814B1 Monitor and control using mid-infrared spectroscopy for vapor hydrogen peroxide processing techniques |
| 09/21/2005 | EP1294877B1 Cgi-69 compositions and methods of use |
| 09/21/2005 | EP1276904A4 Methods of using semiconductor nanocrystals in bead-based nucleic acid assays |
| 09/21/2005 | EP1234176A4 System and method for generating a profile of particulate components of a body fluid sample |
| 09/21/2005 | EP1212613A4 Hematology control and system for multi-parameter hematology measurements |
| 09/21/2005 | EP1212082A4 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies |
| 09/21/2005 | EP1191037B1 Means of stabilizing hemoglobins |
| 09/21/2005 | EP1129188B1 Pge synthase and methods and means for modulating its activity |
| 09/21/2005 | EP1056544B1 Continuous magnetic separation of components from a mixture |
| 09/21/2005 | EP1027601B1 In vitro tissue testing system |
| 09/21/2005 | EP0974057B1 Methods to detect hk2 polypeptides |
| 09/21/2005 | EP0934520B1 Oil quality sensor |
| 09/21/2005 | EP0856067A4 A binary coding method for use in combinatorial chemistry |
| 09/21/2005 | EP0793721B1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof |
| 09/21/2005 | EP0792364B1 Lgmd gene coding for a calcium dependent protease |
| 09/21/2005 | EP0776337B1 Growth differentiation factor-11 |
| 09/21/2005 | EP0752853B1 Human brain phosphodiesterase |
| 09/21/2005 | CN2727744Y Porous micro-biochip |
| 09/21/2005 | CN2727743Y Urinalysis test paper strip (H10-II) |
| 09/21/2005 | CN2727742Y Urinalysis test paper strip (H12) |
| 09/21/2005 | CN2727730Y A hydrogen charging-discharging performance testing device by volumetric method |
| 09/21/2005 | CN1672055A Heterologous stimulus-gated ion channels and methods of using same |
| 09/21/2005 | CN1672054A Detecting receptor oligomerization |
| 09/21/2005 | CN1672053A Accessible assay device and method of use |
| 09/21/2005 | CN1672052A Nano-sized optical fluorescence labels and uses thereof |
| 09/21/2005 | CN1672051A Novel probe plate based on antigen-antibody reaction and reagent kit and method using the probe plate |
| 09/21/2005 | CN1672050A Fluorescence polarization assay |
| 09/21/2005 | CN1672049A Rapid detection of bt-cry toxins |
| 09/21/2005 | CN1672048A Optical projection tomography |
| 09/21/2005 | CN1672047A An exposure device |
| 09/21/2005 | CN1672046A Method for identifying substances |
| 09/21/2005 | CN1672045A Agent for detecting malondialdehyde, method of making the same, and test kit for use thereof |
| 09/21/2005 | CN1672044A Method and apparatus for measuring trace ingredients in water |
| 09/21/2005 | CN1672041A Sample analyzing method and sample analyzing device |
| 09/21/2005 | CN1672036A Method and device for in-line measurement of characteristics of the surface coating of a metallurgy product |
| 09/21/2005 | CN1671866A PTHrP-based prediction and diagnosis of bone disease |
| 09/21/2005 | CN1671865A Microparticle based signal amplification method and its application in the detection of analytes |
| 09/21/2005 | CN1671864A Photonic signal reporting of electrochemical events |
| 09/21/2005 | CN1671862A Homogeneous assay of biopolymer binding by means of multiple measurements under varied conditions |
| 09/21/2005 | CN1671861A Lectin pathway deficiency assay |
| 09/21/2005 | CN1671860A Functional cardiomyocytes from human embryonic stem cells |
| 09/21/2005 | CN1671859A Method for identifying individual active entities from complex mixtures |
| 09/21/2005 | CN1671844A Antigenic neisserial peptides |
| 09/21/2005 | CN1671734A CFTR modifier genes and expressed polypeptides useful in treating cystic fibrosis and methods and products for detecting and/or identifying same |
| 09/21/2005 | CN1671722A Campylobacter glycans and glycopeptides |
| 09/21/2005 | CN1671716A Method of treating ischemia reperfusion injury using adenosine receptor antagonists |
| 09/21/2005 | CN1671711A Calcitonin gene related peptide receptor antagonists |
| 09/21/2005 | CN1671644A Compounds that abrogate DNA-damage-induced cell cycle G2 checkpoint and/or augment the anti-cancer activity of DNA-damaging treatments |
| 09/21/2005 | CN1671423A Novel chimeric CD154 |
| 09/21/2005 | CN1671416A Super humanized antibodies |
| 09/21/2005 | CN1671391A Novel methods and compositions for alleviating pain |
| 09/21/2005 | CN1670755A Diagnostic support system for diabetes and storage medium |
| 09/21/2005 | CN1670532A Antibody diagnosing reagent kit for detecting HepatitisType C virus, its preparation and method for detection |
| 09/21/2005 | CN1670531A Biological chip detecting instrument |
| 09/21/2005 | CN1670530A Use of Esat-6 protein in diagnosis of tuberculosis |
| 09/21/2005 | CN1670529A Method for constructing Compound Xueshuantong preparation HPLC fingerprint pattern and method standard fingerprint pattern thereof |
| 09/21/2005 | CN1670527A Cowpea assortment analyzing and determining method based on salting-in-protein graphical spectrum technology |